1fo7 Citations

Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases.

J Biol Chem 275 33650-4 (2000)
Cited: 80 times
EuropePMC logo PMID: 10954699

Abstract

Prion propagation in transmissible spongiform encephalopathies involves the conversion of cellular prion protein, PrP(C), into a pathogenic conformer, PrP(Sc). Hereditary forms of the disease are linked to specific mutations in the gene coding for the prion protein. To gain insight into the molecular basis of these disorders, the solution structure of the familial Creutzfeldt-Jakob disease-related E200K variant of human prion protein was determined by multi-dimensional nuclear magnetic resonance spectroscopy. Remarkably, apart from minor differences in flexible regions, the backbone tertiary structure of the E200K variant is nearly identical to that reported for the wild-type human prion protein. The only major consequence of the mutation is the perturbation of surface electrostatic potential. The present structural data strongly suggest that protein surface defects leading to abnormalities in the interaction of prion protein with auxiliary proteins/chaperones or cellular membranes should be considered key determinants of a spontaneous PrP(C) --> PrP(Sc) conversion in the E200K form of hereditary prion disease.

Reviews - 1fo7 mentioned but not cited (2)

  1. A structural overview of the vertebrate prion proteins. Pastore A, Zagari A. Prion 1 185-197 (2007)
  2. Probing early misfolding events in prion protein mutants by NMR spectroscopy. Giachin G, Biljan I, Ilc G, Plavec J, Legname G. Molecules 18 9451-9476 (2013)

Articles - 1fo7 mentioned but not cited (7)



Reviews citing this publication (19)

  1. Peptide aggregation in neurodegenerative disease. Murphy RM. Annu Rev Biomed Eng 4 155-174 (2002)
  2. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P. Acta Neuropathol 121 21-37 (2011)
  3. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S. Neuropsychiatr Dis Treat 14 2067-2085 (2018)
  4. The consequences of pathogenic mutations to the human prion protein. van der Kamp MW, Daggett V. Protein Eng Des Sel 22 461-468 (2009)
  5. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. Poggiolini I, Saverioni D, Parchi P. Int J Cell Biol 2013 910314 (2013)
  6. The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis. Mastrangelo P, Westaway D. Gene 275 1-18 (2001)
  7. Role of prion protein aggregation in neurotoxicity. Corsaro A, Thellung S, Villa V, Nizzari M, Florio T, Florio T. Int J Mol Sci 13 8648-8669 (2012)
  8. Folding aggregated proteins into functionally active forms. Swietnicki W. Curr Opin Biotechnol 17 367-372 (2006)
  9. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion. Silva JL, Vieira TC, Gomes MP, Rangel LP, Scapin SM, Cordeiro Y. Methods 53 306-317 (2011)
  10. Similar and divergent features in mammalian and yeast prions. Bousset L, Melki R. Microbes Infect 4 461-469 (2002)
  11. Conformational conversion of prion protein in prion diseases. Zhou Z, Xiao G. Acta Biochim Biophys Sin (Shanghai) 45 465-476 (2013)
  12. Subcellular distribution of the prion protein in sickness and in health. Godsave SF, Peters PJ, Wille H. Virus Res 207 136-145 (2015)
  13. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein. Sengupta I, Udgaonkar JB. Chem Commun (Camb) 54 6230-6242 (2018)
  14. Methionine oxidation within the prion protein. Bettinger J, Ghaemmaghami S. Prion 14 193-205 (2020)
  15. Cerebral organoids as a new model for prion disease. Groveman BR, Smith A, Williams K, Haigh CL. PLoS Pathog 17 e1009747 (2021)
  16. Early structural features in mammalian prion conformation conversion. Legname G. Prion 6 37-39 (2012)
  17. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications. Hackl S, Becker CFW. J Pept Sci 25 e3216 (2019)
  18. Molecular advances in understanding inherited prion diseases. Brown DR. Mol Neurobiol 25 287-302 (2002)
  19. Three-dimensional structures of the prion protein and its doppel. Riek R, Lührs T. Clin Lab Med 23 209-225 (2003)

Articles citing this publication (52)